Andrew Little works as an Investor at AbbVie. The firm's known portfolio counts 16 companies.
Is Andrew Little a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Investor at AbbVie, whose known portfolio counts 16 companies
- Zag Bio
- Carisma Therapeutics
- Third Arc Bio
- Accent Therapeutics
- DISCO Pharmaceuticals
- Jnana Therapeutics
- Oisin Biotechnologies
- Soufflé Therapeutics
- Syndeio Biosciences
- Light Horse Therapeutics
- BaseLaunch
- Cephagenix
- and 4 more
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biotech, Cell & Gene, Drug Discovery and Genomics fall inside that listing.
Stage-wise, the deals at AbbVie cluster around Growth, Seed and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether Andrew Little is worth approaching.
Colleagues at AbbVie
Michael Widmann
Associate Director, Portfolio Strategy & Analytics
Chicago, United States
Mayara Doile
Senior Executive
São Paulo, Brazil
Wenwen He
Venture Capital
United States
Tatiana W
Investor & Partner
United States
Christine Hsieh
Venture Partner
Boston, United States
Kevin Ho
Director, Business Development & Acquisitions
San Francisco, United States
Doug Faunce
Executive Director
Irvine, United States
Keith Hamel
Director
Chicago, United States
Frequently asked questions
Who is Andrew Little?
Andrew Little is a corporate venture investor based in Boston, Massachusetts, United States, listed as Investor at AbbVie. The known portfolio of that firm counts 16 companies. That portfolio belongs to the firm, not to Andrew Little personally.
What does Andrew Little invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell & Gene, Drug Discovery and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Andrew Little invest at?
AbbVie appears in Growth, Seed and Series A rounds across its known deals, and Andrew Little is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Andrew Little listed at?
Andrew Little is listed as Investor at AbbVie. 8 other people in the database share a firm with Andrew Little.
How do I contact Andrew Little?
A LinkedIn page is on file for Andrew Little. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal